Abiomed, Inc.
$381.02+0.00%(+$0.00)
TickerSpark Score
73/100
50
Valuation
75
Profitability
50
Growth
92
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABMD research report →
52-Week Range99% of range
Low $219.84
Current $381.02
High $381.99
Companywww.abiomed.com
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.
- CEO
- Michael Minogue
- IPO
- 1987
- Employees
- 2,003
- HQ
- Danvers, MA, US
Price Chart
+6.48% · this period
Valuation
- Market Cap
- $17.18B
- P/E
- 126.85
- P/S
- 16.65
- P/B
- 11.52
- EV/EBITDA
- 34.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 81.76%
- Op Margin
- 36.12%
- Net Margin
- 13.23%
- ROE
- 9.64%
- ROIC
- 17.39%
Growth & Income
- Revenue
- $1.03B · 21.74%
- Net Income
- $136.50M · -39.47%
- EPS
- $3.00 · -40.00%
- Op Income
- $372.69M
- FCF YoY
- 12.85%
Performance & Tape
- 52W High
- $381.99
- 52W Low
- $219.84
- 50D MA
- $351.42
- 200D MA
- $291.67
- Beta
- 0.00
- Avg Volume
- 1.70M
Get TickerSpark's AI analysis on ABMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 22, 22 | SUTTER MARTIN P | sell | 123,370 |
| Dec 22, 22 | PUHY DOROTHY E | sell | 11,335 |
| Dec 22, 22 | Trapp Todd A | other | 26,023 |
| Dec 22, 22 | Trapp Todd A | sell | 26,023 |
| Dec 22, 22 | Plano Matthew T. | other | 12,490 |
| Dec 22, 22 | Plano Matthew T. | sell | 12,490 |
| Dec 22, 22 | MINOGUE MICHAEL R | other | 96,265 |
| Dec 22, 22 | MINOGUE MICHAEL R | sell | 96,265 |
| Dec 22, 22 | Greenfield Andrew J | other | 27,458 |
| Dec 22, 22 | Greenfield Andrew J | sell | 27,458 |
Our ABMD Coverage
We haven't published any research on ABMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ABMD Report →